FRANKLIN, Mass., May 27, 2020 /PRNewswire/ -- After almost 10 years of service as the CEO of Tegra Medical and as Head of the Medical division within the SFS Group, J. Mark King has decided to retire as of August 1, 2020. The Board of Directors and the Group Executive Board thank J. Mark King for his many years of service, his contribution to the development of Tegra Medical and its integration into the SFS Group.
The MedTech industry is an important market segment for the SFS Group. It is the strategic goal to further strengthen and to grow SFS' position through the Tegra Medical brand in the MedTech market. Substantial investments in people and capacities are planned in order to pursue this goal.
About Tegra Medical
Known as the company that brings medical devices to life, Tegra Medical is focused exclusively on the medical device industry, providing true end-to-end solutions from prototyping to full production, and from complex components to finished medical devices. Offering a wide range of manufacturing technologies, the company creates devices used in cutting-edge procedures for leading surgical, interventional and orthopaedic companies. Tegra Medical has four ISO 13485 and FDA registered, QSR compliant manufacturing locations in the U.S. and Costa Rica, plus several sales offices in the U.S. and Europe. Tegra Medical is a member of SFS.
China Jo-Jo Drugstores, Inc. ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that it has entered...
MyFitnessPal, the #1 global nutrition and food tracking app, today announced that it has appointed Tim Holley as Chief Product Officer. In this role, Tim will apply his extensive experience driving sustained growth through reliable delivery of...
MDI Health, an AI-powered solution that optimizes personalized medication management at scale, announced that it has been selected as winner of the "Best New Technology Solution for Medication Management" award in the 8th annual MedTech Breakthrough...
Lumenis Be Ltd., a leading energy-based medical device company for aesthetic and eye care applications, announced today that triLift is the winner of the highly competitive "Best New Dermatology Technology Solution" award in the 8th annual MedTech...
Helius Medical Technologies, Inc. ("Helius" or the "Company"), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that the Company will release its first quarter 2024...
Medtech Canada, the national association representing Canada's medical technology companies, is very pleased to welcome James Brodie of Johnson & Johnson MedTech as Chair of the Medtech Canada Board of Directors. He is joined by five new board...
